ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1300

The Italian Registry of Autoimmune Congenital Heart Block (Lu.Ne Registry): Report of the First Year of Activity

Micaela Fredi1, Laura Andreoli2, Tiziana Bertero3, Alesandra Bortoluzzi4, Silvia Breda5, Veronica Cappa6, Fulvia Ceccarelli7, Rolando Cimaz8, Salvatore De Vita9, Emma Di Poi10, Franco Franceschini11, Maria Gerosa12, Marcello Govoni4, Ariela Hoxha13, Andrea Lojacono14, Luca Marozio15, Alessandro Mathieu16, Antonina Minniti17, Marina Muscarà18, Melissa Padovan4, Matteo Piga16, Roberta Priori7, Véronique Ramoni19, Amelia Ruffatti13, Marta Tonello13, Sonia Zatti20, Stefano Calza6, Antonio Brucato5 and Angela Tincani2, 1Department of Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 2Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, 3Ospedale Mauriziano, Torino, Italy, 4UOC of Rheumatology, University Hospital S. Anna, Cona Ferrara, Italy, 5Struttura Complessa Medicina Interna, ASST Papa Giovanni XXIII, Bergamo, Italy, 6Unit of Biostatistics and Biomathematics & Unit of Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy, 7UO Complessa Reumatologia, Policlinico Umberto I Università Sapienza di Roma, Rome, Italy, 8Pediatric Rheumatology, Anna Meyer Children's Hospital-University of Firenze, Florence, Italy, 9Rheumatology Clinic, Academic Hospital S. M. della Misericordia, Medical Area Department, University of Udine, Italy, Udine, Italy, 10Clinica di Reumatologia, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy, 11Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 12Istituto Ortopedico Gaetano Pini, University of Milan, Milano, Italy, 13Unità di Reumatologia, Dipartimento di Medicina-DIMED, Università di Padova., Padova, Italy, 14Obstetrics and Gynecology, Spedali Civili and University of Brescia, Brescia, Italy, 15Ginecologia e Ostetricia 1, Dipartimento di Scienze Chirurgiche, Università di Torino, Torino, Italy, 16Unit and Chair of Rheumatology, University Hospital of Cagliari, Cagliari, Italy, 17UO Complessa Reumatologia, Policlinico Umberto I Università Sapienza di Roma, Roma, Italy, 18Reumatologia ASST Ospedale Niguarda, Milano, Italy, 19Rheumatology, Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, 20U.O. Ginecologia e Ostetricia ASST Spedali Civili, Brescia, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autoantibodies, heart block and pregnancy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Neonatal Lupus (NL) is a rare syndrome caused by placental transfer of maternal anti-Ro/SSA and anti-La/SSB autoantibodies to the fetus. Cardiac manifestations may comprise autoimmune congenital heart block (CHB) and dilated cardiomiopathy (DCM). The prevalence of CHB has been estimated as 1-2% in anti-Ro/SSA-positive women while the recurrence rate is 16-19%. The rarity of these conditions requires the establishment of collaborative registries in order to improve our knowledge on the management of CHB. Here we report the preliminary data of the Italian Registry of the autoimmune congenital heart block, which was created in the frame of the Italian Society for Rheumatology in 2016.

Methods:

The aim was to collect retrospective and prospective pregnancies complicated with CHB in patients with anti-Ro/SSA and/or anti-La/SSB antibodies. The study was approved by the Ethic Committee of the Promoting Centre in July 2016 and it has been approved by other eight Italian Institutions. Data regarding demography, maternal treatment before and after CHB detection, neonatal outcome, maternal and neonatal follow-up were collected through an online electronic datasheet prepared in a Research Electronic Data Capture (REDCap) platform. Two-tailed Student’s t-test for continuous variables, Fisher’s exact test or Yates’s Chi squared test for categorical variables were applied. The statistical software Stata/SE14.2 was used.

Results:

Seventy-five pregnancies complicated with the detection of CHB were collected in 73 women. CHB was detected in utero in 68 cases (90.6%), 5(6.7%) neonatal cases, 2(2.7%) unknown. Demographic description of the cohort, degree of CHB and treatment are reported in the table. The death of the child was observed in 17 (23.2%) cases: 7 fetal-deaths,5 termination of pregnancy and 5 postnatal death. Maternal and fetal risk factors for fetal mortality were analyzed for possible associations. At univariate analysis, factors associated with death were hydrops (p=0.065) and pericardial effusion (p=0.025).

Conclusion:

The Lu.Ne registry is an ongoing project aiming at collecting all cases of CHB referred to Italian Rheumatology Centres. Our preliminary data confirmed that hydrops and pericardial effusion are risk factors for fetal death. Conversely, we found that the majority of the mothers (58%) whose pregnancy was affected by CHB had a formal diagnosis of systemic autoimmune disease. This is in contrast with other registries showing that usually CHB was incidentally detected in healthy women. Probably such discrepancy is related to the recruiting Centres all belonging to Rheumatology Society. The collection of CHB cases from Gynecological and Pediatric Cardiology Centres, planned in the next months, will complete our analysis


Disclosure: M. Fredi, None; L. Andreoli, None; T. Bertero, None; A. Bortoluzzi, None; S. Breda, None; V. Cappa, None; F. Ceccarelli, None; R. Cimaz, None; S. De Vita, None; E. Di Poi, None; F. Franceschini, None; M. Gerosa, None; M. Govoni, None; A. Hoxha, None; A. Lojacono, None; L. Marozio, None; A. Mathieu, None; A. Minniti, None; M. Muscarà, None; M. Padovan, None; M. Piga, None; R. Priori, None; V. Ramoni, None; A. Ruffatti, None; M. Tonello, None; S. Zatti, None; S. Calza, None; A. Brucato, None; A. Tincani, None.

To cite this abstract in AMA style:

Fredi M, Andreoli L, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Minniti A, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tonello M, Zatti S, Calza S, Brucato A, Tincani A. The Italian Registry of Autoimmune Congenital Heart Block (Lu.Ne Registry): Report of the First Year of Activity [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-italian-registry-of-autoimmune-congenital-heart-block-lu-ne-registry-report-of-the-first-year-of-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-italian-registry-of-autoimmune-congenital-heart-block-lu-ne-registry-report-of-the-first-year-of-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology